GoldenGolden
Andera Partners

Andera Partners

Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP), is a Paris based venture capital firm.

Andera Partners, formerly Edmond de Rothschild Investment Partners, is a venture capital firm. They invest across four strategies, BioDiscovery, Cabestan Capital, Winch Capital and ActoMezz. Across their four strategies, they have €2.3 billion under management with 95 portfolio companies.

BioDiscovery

Andera Partners' BioDiscovery invests in companies working in medical therapy, products and technologies from pre-clinical to proof of principles to commercialization.

Cabestan Capital

Andera Partners' Cabestan Capital makes equity investments in French companies to develop them into cross border companies.

Winch Capital

Andera Partners' Winch Capital invests in European companies with a revenue of €30 millioin to €300 million, in which they invest between €12 million to €45 million.

ActoMezz

Andera Partners' ActoMezz invests between €5 to €45 million in small to mid-cap French companies who are either sponsorless, need capital for growth or looking to maximize the participation of directors in transfer transactions.

Investment

Andera Partners has made investments in Inotrem, AM Pharma, SANIFIT, HR Path, Arvelle Therapeutics, Grey Wolf Therapeutics, HighLife, Atlantic Therapeutics, Artios Pharma and ReViral.

They have exited their investments in Axonics Modulation Technologies, Vivoryon Therapeutics, LogicBio Therapeutics, Poxel, SuperSonic Imagine, EOS Imaging, Exclusive Group, CellNovo, Verona Pharma and Noxxon Pharma.

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Andera Partners : A change of scale

April 12, 2018

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Conor Hale
February 9, 2021
FierceBiotech
MedLumics has raised €18 million, or about $21.8 million, to move toward clinically proving its optically guided heart ablation catheter for treating atrial fibrillation.
MedLumics
February 10, 2021
www.prnewswire.com:443
/PRNewswire/ -- MedLumics, a privately held medical device company developing AblaView®, the first optically-guided real-time ablation catheter system for the...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.